Bausch Health will pay $1.75 per share plus up to $350 million in aggregate sales milestonesTransaction expected to close in the third quarter of 2025CUPERTINO, Calif., Aug. 12, 2025 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the second quarter ended June 30, 2025 and provided an update on the previously announced acquisition of DURECT by Bausch Health Companies Inc. (Bausch Health).Recent business highlights and updates: In July 2025, DURECT announced that it en ...